Alpha Profiles · Company Profile
Merck & Co., Inc.
Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health.
https://registry.alpha.ac/companies/merck-co-inc
- Entity
- Public listing published
- Primary listing
- NYSE: MRK
- Verification
- Partially verified
- Last reviewed
- 2026-09-05T21:30:34.215281+00:00
Overview
Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhil
Canonical AEGIS identity graph
Executive leadership
Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.
Executive team
14 public records
Executive Vice President and Chief Human Resources Officer
- State
- confirmed
- Effective
- From Feb 24, 2026
- Confidence
- 94%
- Evidence
- MRK 10-K executive officersFeb 24, 2026
Executive Vice President and Chief Human Resources Officer
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- MRK executive roster sourceMay 3, 2026
Executive Vice President and Chief Financial Officer
- State
- confirmed
- Effective
- From Feb 24, 2026
- Confidence
- 94%
- Evidence
- MRK 10-K executive officersFeb 24, 2026
Senior Vice President, Chief Marketing Officer, Human Health
- State
- confirmed
- Effective
- From Feb 24, 2026
- Confidence
- 94%
- Evidence
- MRK 10-K executive officersFeb 24, 2026
Senior Vice President Finance Global Controller
- State
- confirmed
- Effective
- From Feb 24, 2026
- Confidence
- 94%
- Evidence
- MRK 10-K executive officersFeb 24, 2026
Senior Vice President, Human Health Operations
- State
- confirmed
- Effective
- From Feb 24, 2026
- Confidence
- 94%
- Evidence
- MRK 10-K executive officersFeb 24, 2026
Executive Vice President, Chief Information and Digital Officer
- State
- confirmed
- Effective
- From Feb 24, 2026
- Confidence
- 94%
- Evidence
- MRK 10-K executive officersFeb 24, 2026
- State
- confirmed
- Effective
- From Feb 24, 2026
- Confidence
- 94%
- Evidence
- MRK 10-K executive officersFeb 24, 2026
Executive Vice President and General Counsel
- State
- confirmed
- Effective
- From Feb 24, 2026
- Confidence
- 94%
- Evidence
- MRK 10-K executive officersFeb 24, 2026
Senior Vice President and President Merck U.S. Human Health
- State
- confirmed
- Effective
- From Feb 24, 2026
- Confidence
- 94%
- Evidence
- MRK 10-K executive officersFeb 24, 2026
Senior Vice President and President MSD International Human Health
- State
- confirmed
- Effective
- From Feb 24, 2026
- Confidence
- 94%
- Evidence
- MRK 10-K executive officersFeb 24, 2026
Executive Vice President and President, Merck Animal Health
- State
- confirmed
- Effective
- From Feb 24, 2026
- Confidence
- 94%
- Evidence
- MRK 10-K executive officersFeb 24, 2026
Chairman, Chief Executive Officer and President
- State
- confirmed
- Effective
- From Feb 24, 2026
- Confidence
- 94%
- Evidence
- MRK 10-K executive officersFeb 24, 2026
Executive Vice President and President, Merck Manufacturing Division
- State
- confirmed
- Effective
- From Feb 24, 2026
- Confidence
- 94%
- Evidence
- MRK 10-K executive officersFeb 24, 2026
Governance leadership
Boards & Committees
Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.
Record as of Sep 5, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.
Board roles
13 public records- State
- confirmed
- Effective
- From Jan 1, 2021
- Confidence
- 95%
- Evidence
- Merck director board sourceApr 8, 2026
- State
- unconfirmed
- Effective
- From Jan 1, 2020
- Confidence
- 85%
- Evidence
- Merck DEF 14A 2026-04-08Apr 8, 2026
- State
- unconfirmed
- Effective
- From Jan 1, 2022
- Confidence
- 85%
- Evidence
- Merck DEF 14A 2026-04-08Apr 8, 2026
- State
- unconfirmed
- Effective
- From Jan 1, 2018
- Confidence
- 85%
- Evidence
- Merck DEF 14A 2026-04-08Apr 8, 2026
- State
- confirmed
- Effective
- From Jan 1, 2020
- Confidence
- 95%
- Evidence
- Merck director board sourceJan 1, 2020
- State
- unconfirmed
- Effective
- From Jan 1, 2019
- Confidence
- 85%
- Evidence
- Merck DEF 14A 2026-04-08Apr 8, 2026
- State
- confirmed
- Effective
- From Jan 1, 2015
- Confidence
- 95%
- Evidence
- Merck director board sourceJan 1, 2015
- State
- unconfirmed
- Effective
- From Jan 1, 1995
- Confidence
- 85%
- Evidence
- Merck DEF 14A 2026-04-08Apr 8, 2026
- State
- confirmed
- Effective
- From Jan 1, 2015
- Confidence
- 95%
- Evidence
- Merck director board sourceJan 1, 2015
- State
- confirmed
- Effective
- From Jan 1, 2020
- Confidence
- 95%
- Evidence
- Merck director board sourceJan 1, 2020
- State
- confirmed
- Effective
- From Jan 1, 2021
- Confidence
- 95%
- Evidence
- Merck director board sourceJan 1, 2021
- State
- unconfirmed
- Effective
- From Jan 1, 2025
- Confidence
- 85%
- Evidence
- Merck DEF 14A 2026-04-08Apr 8, 2026
- State
- confirmed
- Effective
- From Jan 1, 2007
- Confidence
- 95%
- Evidence
- Merck director board sourceJan 1, 2007
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-09-05T21:30:34.215281+00:00
Merck & Co., Inc. Form 10-K (filed 2026-02-24)
Supports Official website
Reviewed 2026-08-29T22:19:02Z